Connection

Donna Mancini to Time Factors

Back to Details
This is a "connection" page, showing publications Donna Mancini has written about Time Factors.
Donna Mancini
Connection Strength
0.024
Time Factors
  1. Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity? Cardiovasc Drugs Ther. 2019 02; 33(1):87-95.
    View in: PubMed
    Score: 0.009
  2. The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis. J Heart Lung Transplant. 2017 Jun; 36(6):633-639.
    View in: PubMed
    Score: 0.008
  3. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. J Heart Lung Transplant. 2015 Aug; 34(8):1024-32.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.